Bavarian Nordic A/S (BVNKF)
21.20
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Bavarian Nordic Total Assets (Quarterly): 1.970B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.970B |
December 31, 2023 | 2.131B |
September 30, 2023 | 1.898B |
June 30, 2023 | 2.188B |
March 31, 2023 | 1.929B |
December 31, 2022 | 1.783B |
September 30, 2022 | 1.625B |
June 30, 2022 | 1.689B |
March 31, 2022 | 1.799B |
December 31, 2021 | 1.840B |
September 30, 2021 | 1.578B |
June 30, 2021 | 1.602B |
March 31, 2021 | 1.537B |
December 31, 2020 | 1.448B |
September 30, 2020 | 1.490B |
June 30, 2020 | 1.394B |
March 31, 2020 | 1.330B |
December 31, 2019 | 1.057B |
September 30, 2019 | 375.61M |
June 30, 2019 | 407.07M |
March 31, 2019 | 415.05M |
December 31, 2018 | 468.90M |
September 30, 2018 | 482.84M |
June 30, 2018 | 489.49M |
March 31, 2018 | 500.89M |
Date | Value |
---|---|
December 31, 2017 | 508.05M |
September 30, 2017 | 461.58M |
June 30, 2017 | 471.98M |
March 31, 2017 | 413.94M |
December 31, 2016 | 401.56M |
September 30, 2016 | 388.73M |
June 30, 2016 | 371.07M |
March 31, 2016 | 283.19M |
December 31, 2015 | 291.39M |
September 30, 2015 | 322.67M |
June 30, 2015 | 333.82M |
March 31, 2015 | 357.19M |
December 31, 2014 | 308.13M |
September 30, 2014 | 215.43M |
June 30, 2014 | 229.64M |
March 31, 2014 | 245.33M |
December 31, 2013 | 268.79M |
September 30, 2013 | 263.14M |
June 30, 2013 | 261.68M |
March 31, 2013 | 238.76M |
December 31, 2012 | 272.80M |
September 30, 2012 | 284.66M |
June 30, 2012 | 282.72M |
March 31, 2012 | 337.48M |
December 31, 2011 | 344.44M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
375.61M
Minimum
Sep 2019
2.188B
Maximum
Jun 2023
1.554B
Average
1.613B
Median
Total Assets (Quarterly) Benchmarks
Genmab A/S | 5.306B |
Ascendis Pharma A/S | 866.62M |
Galecto Inc | 32.48M |
Evaxion Biotech AS | 12.89M |
IO Biotech Inc | 128.16M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 498.58M |
Shareholders Equity (Quarterly) | 1.472B |
Debt to Equity Ratio | 0.0016 |
Current Ratio | 1.641 |
Net Debt Paydown Yield | 2.55% |